CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 7, 2006--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today the appointment of Akshay K. Vaishnaw, M.D., Ph.D., to the position of Vice President, Clinical Research. Dr. Vaishnaw has extensive clinical experience in the industry as well as in the academic and hospital settings. At Alnylam, he will be responsible for leading and managing the company's clinical organization and will be a member of the management team.
